| Target Price | $663.00 |
| Price | $654.80 |
| Potential |
1.25%
register free of charge
|
| Number of Estimates | 32 |
|
32 Analysts have issued a price target Thermo Fisher Scientific 2027 .
The average Thermo Fisher Scientific target price is $663.00.
This is
1.25%
register free of charge
$787.50
20.27%
register free of charge
$559.19
14.60%
register free of charge
|
|
| A rating was issued by 36 analysts: 29 Analysts recommend Thermo Fisher Scientific to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Thermo Fisher Scientific stock has an average upside potential 2027 of
1.25%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 44.56 | 48.35 |
| 3.91% | 8.51% | |
| EBITDA Margin | 24.44% | 26.03% |
| 3.19% | 6.52% | |
| Net Margin | 15.05% | 19.50% |
| 1.84% | 29.60% |
31 Analysts have issued a sales forecast Thermo Fisher Scientific 2026 . The average Thermo Fisher Scientific sales estimate is
This results in the following potential growth metrics:
26 Analysts have issued an Thermo Fisher Scientific EBITDA forecast 2026. The average Thermo Fisher Scientific EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
32 Thermo Fisher Scientific Analysts have issued a net profit forecast 2026. The average Thermo Fisher Scientific net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 17.74 | 25.37 |
| 7.26% | 43.01% | |
| P/E | 25.81 | |
| EV/Sales | 5.80 |
32 Analysts have issued a Thermo Fisher Scientific forecast for earnings per share. The average Thermo Fisher Scientific EPS is
This results in the following potential growth metrics and future valuations:
Thermo Fisher Scientific...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| CLSA |
Locked
➜
Locked
|
Locked | Sep 03 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 27 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jul 27 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jul 06 2026 |
| Bernstein |
Locked
➜
Locked
|
Locked | Jun 26 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
CLSA:
Locked
➜
Locked
|
Sep 03 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 27 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jul 27 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jul 06 2026 |
|
Locked
Bernstein:
Locked
➜
Locked
|
Jun 26 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


